Insiders Indivior PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:05 2024-06-03 am EDT			5-day change	1st Jan Change
1,445 ^GBX	0.00%		+1.19%	+21.94%

May. 23	Indivior Confirms FY24 Outlook	MT
May. 23	Transcript : Indivior PLC - Shareholder/Analyst Call

Indivior PLC Announces Board Committee Changes	May. 10	CI
Indivior PLC Appoints David E. Wheadon, M.D. as Independent Non-Executive Director, Effective from June 1, 2024	Mar. 21	CI
Indivior CCO Richard Simkin sells GBP1 million in shares	Mar. 18	AN
Indivior chief commercial officer sells GBP500,000 in shares	Mar. 08	AN
Oxford Nanopore Technologies top team buys shares	Mar. 07	AN
Indivior plans up to USD100 million share buyback programme	Nov. 17	AN
Indivior to keep Scopia's Jerome Lande on board as agreement extended	Nov. 17	AN
Indivior PLC Announces Executive Changes	Nov. 09	CI
Indivior PLC Announces the Changes to the Structure and Composition of Its Board Committees Effective October 1, 2023	23-09-29	CI
Indivior division chief sells GBP1.7 million shares	23-05-10	AN
Indivior PLC Announces Board and Committee Changes	23-02-16	CI
Indivior plc Announces Executive Changes	22-07-28	CI
Indivior Names Nina DeLorenzo Chief Global Impact Officer	22-06-16	CI
Alliance Pharma Chair to Step Down in 2023; Successor Named	22-05-18	MT
Indivior PLC Appoints Barbara Ryan as Independent Non-Executive Director, Effective June 1, 2022	22-04-27	CI
Jerome Lande to Step Down as Member of the Audit Committee of Indivior PLC	22-04-25	CI
Indivior plc Appoints Juliet Thompson as Chair of Audit Committee	21-04-09	CI
Indivior PLC Announces Board Appointments	21-03-24	CI
Indivior PLC Announces Resignation of DanielTassé as Non-Executive Director	21-01-11	CI
Indivior PLC Announces the Appointment of Ryan Preblick as Chief Financial Officer	20-11-20	CI

No results for this search